Menu Search
Equities

Jack Nathan Medical Corp

JNHMF:QBB

Jack Nathan Medical Corp

Actions
  • Price (USD)0.0332
  • Today's Change0.00 / 0.00%
  • Shares traded11.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Oct 31 2024 13:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Jack Nathan Medical Corp., operating as Jack Nathan Health, is a Canada-based healthcare network operator. Jack Nathan Health is a healthcare company that is improving access for millions of patients by co-locating physicians and ancillary medical services conveniently inside Walmart stores. Jack Nathan Health provides patient care, made possible through patient-centric physicians, a variety of medical services, technology, and programs, designed to put patients first. In Canada, the Company has 80 clinics in Walmart locations in British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, and Quebec and two independent locations for a total of 82 clinics. There are over 22 corporate owned and operated clinics, of which three include Rehab services and six include MedSpa services. In Mexico, the Company has over 155 corporate owned and operated clinics in Walmart locations, five clinics inside Walmart Distribution Centers servicing Walmart Associates, and one Multidisciplinary clinic.

  • Revenue in CAD (TTM)21.02m
  • Net income in CAD-8.55m
  • Incorporated2017
  • Employees24.00
  • Location
    Jack Nathan Medical Corp6-6150 Highway 6,, Suite 491WOODBRIDGE L4H 0R6CanadaCAN
  • Phone+1 (416) 637-2240
  • Fax+1 (416) 663-5000
  • Websitehttps://www.jacknathanhealth.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.